ZGOO Holdings Co., Ltd.
221800
企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
ZGOO Holdings Co., Ltd. transferred its entire existing in-vitro diagnostic contract testing service and medical information system (medical IT) business to Yutu Bio Co., Ltd., a newly established spin-off company, through a simple physical split with a split date of May 1, 2026, and converted itself into a holding company structure whose main business is the ownership, management, and investment of subsidiary equity (split registration date: May 15, 2026; trade name changed from Yutu Bio Co., Ltd. to ZGOO Holdings Co., Ltd.). This split was carried out by allocating the total number of shares issued by the newly established spin-off company upon its incorporation to the company, the surviving entity of the split, so there is no change in the company's shareholder composition or equity ratio, and there is no impact on the consolidated financial statements. As of the reporting date, the company does not qualify as a holding company under the Monopoly Regulation and Fair Trade Act.
代表理事
Lee Jaeung
成立日期
2009年1月2日
法人类型
韩国创业板
行业分类
Testing and analysis services of composition and purity of materials
法人注册号
11011-4022325
营业执照号
113-86-26732
电话号码
070-4492-2727
传真号码
02-941-0482
网站
www.zgoo.xyz
公司地址
321-1 Ttukseom-ro, Seongdong-gu, Seoul
产品与服务
评论